News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ErgoMed Signs Co-Development Deal With CeNeS Pharmaceuticals PLC (CEN.L)


7/13/2006 5:02:21 PM

Ergomed today announced that it has signed a co-development deal with CeNeS Pharmaceuticals to take CNS5161, a novel NMDA antagonist, into a Phase II trial programme for neuropathic pain. Terms of the deal were not disclosed.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES